These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


352 related items for PubMed ID: 11280603

  • 1. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters.
    Thike AA, Chng MJ, Fook-Chong S, Tan PH.
    Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603
    [Abstract] [Full Text] [Related]

  • 2. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 3. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Breast carcinoma in women 35 years and younger: a pathological study.
    Fernandopulle SM, Cher-Siangang P, Tan PH.
    Pathology; 2006 Jun 01; 38(3):219-22. PubMed ID: 16753742
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].
    Yang JQ, Chen L, Xing TY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May 01; 35(3):334-6, 357. PubMed ID: 15181828
    [Abstract] [Full Text] [Related]

  • 13. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G, Anzalone R, Corrao S, Magno F, Rappa F, Marasà S, Czarnecka AM, Marasà L, Sergi C, Zummo G, Cappello F.
    Histopathology; 2008 Jan 01; 52(2):203-12. PubMed ID: 18184269
    [Abstract] [Full Text] [Related]

  • 14. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
    Ikpatt OF, Ndoma-Egba R.
    Cent Afr J Med; 2003 Jan 01; 49(11-12):122-6. PubMed ID: 15301464
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S, Schröder W, Steinhagen G, Koch R, Veuskens U, Schmitz FJ, Handt S, Böcking A.
    Anticancer Res; 1997 Jan 01; 17(6D):4723-9. PubMed ID: 9494596
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.